Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Dec 30:2024.08.31.606944.
doi: 10.1101/2024.08.31.606944.

Astrocyte-derived MFG-E8 facilitates microglial synapse elimination in Alzheimer's disease mouse models

Affiliations

Astrocyte-derived MFG-E8 facilitates microglial synapse elimination in Alzheimer's disease mouse models

Dimitra Sokolova et al. bioRxiv. .

Abstract

Region-specific synapse loss is an early pathological hallmark in Alzheimer's disease (AD). Emerging data in mice and humans highlight microglia, the brain-resident macrophages, as cellular mediators of synapse loss; however, the upstream modulators of microglia-synapse engulfment remain elusive. Here, we report a distinct subset of astrocytes, which are glial cells essential for maintaining synapse homeostasis, appearing in a region-specific manner with age and amyloidosis at onset of synapse loss. These astrocytes are distinguished by their peri-synaptic processes which are 'bulbous' in morphology, contain accumulated p62-immunoreactive bodies, and have reduced territorial domains, resulting in a decrease of astrocyte-synapse coverage. Using integrated in vitro and in vivo approaches, we show that astrocytes upregulate and secrete phagocytic modulator, milk fat globule-EGF factor 8 (MFG-E8), which is sufficient and necessary for promoting microglia-synapse engulfment in their local milieu. Finally, we show that knocking down Mfge8 specifically from astrocytes using a viral CRISPR-saCas9 system prevents microglia-synapse engulfment and ameliorates synapse loss in two independent amyloidosis mouse models of AD. Altogether, our findings highlight astrocyte-microglia crosstalk in determining synapse fate in amyloid models and nominate astrocytic MFGE8 as a potential target to ameliorate synapse loss during the earliest stages of AD.

PubMed Disclaimer

Conflict of interest statement

SH has received speaking fees from Eisai Ltd, Novo Nordisk, and Alnylam; SH receives research funding from Eisai Ltd; SH has a collaborative project with Ionis Ltd. DS receives research funding from AstraZeneca. During this research, OJF was employed by AstraZeneca; OJF is now employed by MSD. All the other authors declare that they have no competing interests.

Figures

Fig 1.
Fig 1.. Identification of a unique p62-accumulated bulbous astrocyte subset in the NL-F KI hippocampus.
A) Schematic of NL-F KI mouse model and viral tdTomato labeling strategy to visualize complex hippocampal astrocyte processes. Immunostaining for GFAP (green) post intra-hippocampal AAV2/5-GfaABC1D-tdTomato (tdTomato) (magenta) injection. Scale bar = 10 μm. B) Representative images of tdTomato-labeled astrocytes (magenta) in the 6-mo WT and NL-F KI hippocampus. Scale bar = 10 μm. Images are modified on ImageJ as shown by white ROI. C) Quantification of the tdTomato labeled astrocyte area (μm2) using ImageJ. Transparent points = individual astrocytes (16–58 astrocytes per mouse; 104 WT and 183 NL-F KI astrocytes sampled in total); full points = mouse average of ROIs (n=4–6 male mice per genotype). Unpaired two-tailed student’s t-test on mouse average. D) Representative images of tdTomato-labeled (magenta) astrocytes in the 6-mo hippocampus showing a bushy and bulbous astrocyte. Scale bar = 20 μm. Insets show representative zoom-ins of processes. Scale bar = 2 μm. E) Quantification of the tdTomato-labeled astrocytic volume (μm3) using Imaris 3D surface rendering. Transparent points = individual astrocytes (5–7 astrocytes per condition; 35 NL-F KI bushy and 31 NL-F KI bulbous astrocytes sampled in total); full points = mouse average of ROIs (n=6 male mice). Paired two-tailed student’s t-test on mouse average. F) Representative image of p62 (green) and S100β (magenta) immunoreactivity in the hippocampus. Scale bar = 10 μm. Images are modified on ImageJ as shown by white ROI. Inset shows representative Imaris 3D reconstruction of p62 within the S100β+ astrocytic surface. G) Quantification of the % colocalization between p62 and S100β+ bulbous astrocytes in the hippocampus using ImageJ. Transparent points = individual astrocytes (3 astrocytes per mouse; 15 astrocytes sampled in total per condition), full points = mouse average of ROIs (n=5 male mice). Ratio paired two-tailed student’s t-test on mouse average. H) Representative image of p62 (green) immunoreactivity in the 6-mo NL-F KI hippocampus. Scale bar = 400 μm. Insets highlight some regions with bulbous astrocytes. I) Representative images of p62 (green) and S100β (magenta) immunoreactivity in the 2-, 6- and 20-mo hippocampus. Scale bar = 10 μm. Insets show representative zoom-ins of p62-immunostaining. J) Quantification of the number of p62+ S100β+ bulbous astrocytes per mm2 in the hippocampus in 6-mo (left) and 20-mo (right). Each point = 1 mouse (n=5–6 male mice). Two-tailed Mann-Whitney (6-mo) or unpaired two-tailed student’s t-test (20-mo) on mouse average. Dashed line represents graph split. K) Representative images of p62 (green) and S100β (magenta) immunoreactivity in the hippocampus, motor cortex (M1) and thalamus. Scale bar = 10 μm. Insets show representative zoom-ins of p62-immunostaining. L) Quantification of the number of p62+ S100β+ bulbous astrocytes per mm2 in hippocampus, motor cortex (M1) and thalamus. Each point = 1 mouse (n=5 male mice). Kruskal-Wallis test (p<0.001) followed by the Dunn’s multiple comparisons test on mouse average. All data shown as mean ± SEM. p-values shown ns P>0.05; *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001.
Fig 2.
Fig 2.. Loss of astrocyte-synapse interactions and increased loss of excitatory post-synaptic marker Homer1 near hippocampal NL-F KI bulbous astrocytes.
A) Schematic of astrocytic-synapse interactions. B-F) Representative images and quantification of astrocytic EAAT1-, excitatory post-synaptic Homer1- and pre-synaptic Synaptophysin-immunoreactive puncta in the 6-mo hippocampal CA1 SR using super-resolution Airyscan confocal microscopy. B) Quantification of the number of colocalized Homer1- and Synaptophysin-immunoreactive spots shown as density per μm3 using Imaris. Transparent points = individual ROIs (3 ROIs per mouse; 15 WT and 21 NL-F KI ROIs sampled in total); full points = mouse average of ROIs (n=5–7 male mice per genotype). Unpaired two-tailed student’s t-test on mouse average. C) Quantification of the number of EAAT1-immunoreactive spots shown as density per μm3 using Imaris. Transparent points = individual ROIs (3 ROIs per mouse; 15 WT and 21 NL-F KI ROIs sampled in total); full points = mouse average of ROIs (n=5–7 male mice per genotype). Unpaired two-tailed student’s t-test on mouse average. D) Quantification of the number of colocalized EAAT1, Homer1 and Synaptophysin spots divided by the number of colocalized Homer1 and Synaptophysin spots shown as %. Transparent points = individual ROIs (3 ROIs per mouse; 15 WT and 21 NL-F KI ROIs sampled in total); full points = mouse average of ROIs (n=5–7 male mice per genotype). Unpaired two-tailed student’s t-test on mouse average. E) Quantification of the number of colocalized EAAT1, Homer1 and Synaptophysin spots divided by the number of EAAT1 spots using Imaris shown as %. Transparent points = individual ROIs (3 ROIs per mouse; 15 WT and 21 NL-F KI ROIs sampled in total); full points = mouse average of ROIs (n=5–7 male mice per genotype). Unpaired two-tailed student’s t-test on mouse average. F) Representative image of B-E for EAAT1 (blue), Homer1 (green) and Synaptophysin (red). Scale bar = 1 μm. Insets show regions of triple colocalization. G) Representative images of Ezrin (green) immunoreactivity in the 6-mo NL-F KI hippocampus near bushy or bulbous S100β+ astrocytes (magenta). Scale bar = 10 μm. Images are modified on ImageJ as shown by white ROI. H) Quantification of the total Ezrin spot volume on S100β+ astrocytes/S100β volume using Imaris 3D surface rendering and surface-spot colocalization. Transparent points = individual astrocytes (5–8 astrocytes per condition; 36 NL-F KI bushy and 30 NL-F KI bulbous astrocytes sampled in total); full points = mouse average of ROIs (n=5 male mice). Paired two-tailed student’s t-test on mouse average. I) Representative images for excitatory post-synaptic Homer1-immunoreactive puncta (green) in the 6-mo NL-F KI hippocampus near bushy or bulbous S100β+ astrocytes (magenta) using super-resolution Airyscan confocal microscopy. Scale bar = 1 μm. J) Quantification of the number of Homer1-immunoreactive puncta shown as density per μm3 using Imaris. Transparent points = individual ROIs (3 ROIs per condition; 18 ROIs sampled in total per condition), full points = mouse average of ROIs (n=6 male mice). Wilcoxon matched pairs signed rank test on mouse average. All data shown as mean ± SEM. p-values shown ns P>0.05; *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001.
Fig 3.
Fig 3.. Increased microglia-Homer1 engulfment near hippocampal NL-F KI bulbous astrocytes.
A) Representative 3D rendered images of excitatory post-synaptic Homer1 (white), Lamp1 lysosomes (red) and GFAP (green) in the 6-mo hippocampal CA1 SR. Scale bar = 10 μm. Inset shows representative zoom of Homer1 inside Lamp1+ astrocytic lysosomes. B) Quantification of astrocytic Homer1 engulfment using Imaris 3D surface rendering shown as: Homer1 volume in Lamp1+ lysosomes in GFAP+ astrocytic surface/GFAP volume x100. Transparent points = individual astrocytes (5–10 astrocytes per mouse; 40 WT and 39 NL-F KI astrocytes sampled in total); full points = mouse average of ROIs (n=5 male mice per genotype). Unpaired two-tailed student’s t-test with Welch’s correction on mouse average. C) Representative 3D rendered images of excitatory post-synaptic Homer1 (white), Lamp1 lysosomes (green) and tdTomato (magenta) in the 6-mo hippocampal CA1 SR. Scale bar = 10 μm. Inset shows representative zoom of Homer1 inside Lamp1+ astrocytic lysosomes. D) Quantification of astrocytic Homer1 engulfment using Imaris 3D surface rendering shown as: Homer1 volume in Lamp1+ lysosomes in tdTomato+ astrocytic surface/tdTomato volume x100. Transparent points = individual astrocytes (4–8 astrocytes per condition; 26 WT, 35 NL-F KI bushy and 31 NL-F KI bulbous astrocytes sampled in total), full points = mouse average of ROIs (n=4–6 male mice). Unpaired (WT vs NL-F KI) or paired (NL-F KI bushy vs NL-F KI bulbous) two-tailed student’s t-test on mouse average. Dashed line represents graph split. E) Representative 3D rendered images of excitatory post-synaptic Homer1 (white), CD68 lysosomes (red) and P2Y12 (green) in the 6-mo hippocampal CA1 SR. Scale bar = 10 μm. Inset shows representative zoom of Homer1 inside CD68+ microglial lysosomes. F) Quantification of microglial Homer1 engulfment using Imaris 3D surface rendering shown as: Homer1 volume in CD68+ lysosomes in P2Y12+ microglial surface/P2Y12 volume x100. Transparent points = individual microglia (5–6 microglia per mouse; 36 WT and 28 NL-F KI microglia sampled in total); full points = mouse average of ROIs (n=5–6 male mice per genotype). Two-tailed Mann Whitney test on mouse average. G) Representative 3D rendered images of excitatory post-synaptic Homer1 (white), CD68 lysosomes (red) and P2Y12 (green) in the 6-mo hippocampal CA1 SR near bushy or bulbous tdTomato+ (magenta) astrocytes. Scale bar = 10 μm. Inset shows representative zoom of Homer1 inside CD68+ microglial lysosomes. H) Quantification of microglial Homer1 engulfment using Imaris 3D surface rendering shown as: Homer1 volume in CD68+ lysosomes in P2Y12+ microglial surface/P2Y12 volume x100. Transparent point = individual microglia (5–7 microglia per condition; 32 and 28 microglia sampled in total near (< 5 μm away) bushy and bulbous NL-F KI astrocytes respectively), full points = mouse average of ROIs (n=6 male mice). Paired two-tailed student’s t-test on mouse average. I) Quantification of the number of Iba1+ microglia near bushy or bulbous NL-F KI astrocytes. Transparent points = individual astrocyte regions (4–10 regions per condition; 30 NL-F KI bushy and 33 NL-F KI bulbous astrocyte regions sampled in total); full points = mouse average of ROIs (n=5 male mice). Wilcoxon matched-pairs signed rank test followed by a Bonferroni-Dunn correction on mouse average. J) Representative 3D rendered images of MFG-E8 (green) inside S100β+ (magenta) bushy or bulbous astrocytic processes in the 6-mo NL-F KI hippocampus. Scale bar = 5 μm. K) Quantification of the volume of MFG-E8 within bushy or bulbous S100β+ astrocytic processes per μm3 using Imaris 3D surface rendering. Transparent points = individual astrocytes (3–5 astrocytes per condition; 27 NL-F KI bushy and 30 NL-F KI bulbous astrocytes sampled in total); full points = mouse average of ROIs (n=5 male mice). Paired two-tailed student’s t-test on mouse average. All data shown as mean ± SEM. p-values shown ns P>0.05; *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001.
Fig 4.
Fig 4.. Increased astrocytic MFG-E8 signaling at the onset of synapse loss in the NL-F KI hippocampus.
A) Representative image of RNAScope probing for Mfge8 (green), Aldh1l1+ astrocytes (magenta) and Cx3cr1+ myeloid cells (yellow) in the hippocampus. Scale bar = 25 μm. Inset shows exemplary ROI. B) Quantification of the number of Mfge8 mRNA spots on Aldh1l1+ astrocytes, Cx3cr1+ myeloid cells or Aldh1l1Cx3cr1 cells in the hippocampus using Imaris. Data shown as a percentage of the total number of Mfge8 spots in a large area of interest. Each point = 1 mouse (n=5 female mice). One-way ANOVA (F (2, 12) = 378.9, p<0.0001) followed by Bonferroni’s multiple comparisons post-hoc test on mouse average. C) RT-qPCR probing for Mfge8 expression in FACS sorted ACSA2+CD45 astrocytes and CX3CR1+CD45+CD11b+ microglia. Gene expression is normalized to the geomean of 3 house-keeping genes (Actb, Gapdh and Rpl32) by the Delta CT method. Each point = 1 mouse (n=3–4 female mice). Unpaired two-tailed student’s t-test with a Welch’s correction on mouse average. D) Representative images of MFG-E8 (magenta) and GFAP (green) immunoreactivity in the post-mortem human frontal cortex. Scale bar = 10 μm. E) RNAScope probing for Mfge8 (green) on Slc1a2+ (magenta) astrocytes in the 6-mo WT and NL-F KI hippocampus. Scale bar = 15 μm. F) Quantification of the total number of Mfge8 spots in a large region of interest using Imaris. Each point = 1 mouse (n=4–5 mixed male and female mice per genotype). Unpaired two-tailed student’s t-test on mouse average. G) Quantification of the number of Slc1a2+ astrocytes in a large region of interest using Imaris. Each point = 1 mouse (n=4–5 mixed male and female mice per genotype). Unpaired two-tailed student’s t-test on mouse average. H) Quantification of the number of Mfge8 mRNA spots in the hippocampus shown as percent distribution on Slc1a2+ astrocytic nuclei. Each point = mouse average (n=4–5 mixed male and female mice per genotype). Two-way ANOVA (Interaction: F (2, 21) = 6.188, p<0.01) followed by Bonferroni’s multiple comparisons post-hoc test on Y=log(Y) transformed mouse average. I) Representative images of MFG-E8 (white) immunoreactivity in the 6-mo hippocampal CA1 SR in WT and NL-F KI mice. Scale bar = 30 μm. J) Quantification of MFG-E8 immunoreactivity in large region using ImageJ. Each point = mouse average (n=7 male mice per genotype). Unpaired two-tailed student’s t-test on mouse average. K) Western blot probing for MFG-E8 (55–75 kDa) with respect to GAPDH loading control (39 kDa) in 6-mo WT and NL-F KI hippocampal homogenates. 1 lane is 1 mouse. L) Quantification of MFG-E8/GAPDH using ImageJ densitometry analysis. Each point = mouse average (n=5 male mice per genotype). Unpaired two-tailed student’s t-test on mouse average. M) Representative images of RNAScope followed by immunostaining probing for either Itgav (cyan) and Itgb5 (magenta) integrin mRNA subunits (left) or Itgav (cyan) and Itgb3 (magenta) integrin mRNA subunits (right) with microglial P2Y12 (green) in the hippocampus. Scale bar = 20 (left) and 15 (right) μm. Inset highlight ROIs. N) Flow cytometry probing for CD61 integrin on CD45+CD11b+CX3CR1+ hippocampal microglia from 6-mo WT and NL-F KI mice. O) Quantification of the levels of CD61 on CD45+CD11b+CX3CR1+ microglia. Each point = mouse average (n=5 female mice per genotype). Unpaired two-tailed student’s t-test followed by a Welch’s correction on mouse average. All data shown as mean ± SEM. p-values shown ns P>0.05; *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001.
Fig 5.
Fig 5.. Viral CRISPR-saCas9 deletion of astrocytic MFG-E8 prevents microglia-Homer1 engulfment and excitatory loss in the NL-F KI hippocampus.
A) Schematic of CRISPR-saCas9 paradigm to knock-down Mfge8 from hippocampal astrocytes with spatio-temporal control. Immunostaining for gRNA-mCherry (magenta) and Cas9-HA (green) constructs post-CRISPR-saCas9 injection. Scale bar = 5 nm. Representative image of MFG-E8 (white) immunoreactivity post-CRISPR-saCas9 injection. Scale bar = 1 nm. Inset highlights ROIs. mCherry injection zone drawn with white ROI on ImageJ. B) Representative images of gRNA-mCherry (red) and Cas9-HA (green) constructs with either GFAP (blue, left), NeuN (blue, middle) or Iba1 (blue, right) post-CRISPR-saCas9 injection. Scale bar = 30 μm. C) Quantification of the colocalized mCherry-labeled signal with GFAP+ astrocytes, NeuN+ neurons or Iba1+ microglia in the hippocampus using ImageJ shown as percentage of the total mCherry-labeled signal. Each point = 1 mouse (n=6 mixed male and female mice). Brown-Forsythe (643.8 (2.000, 6.920, p<0.0001) and Welch ANOVA (339.9 (2.000, 8.829), p<0.0001) with Dunnett’s T3 multiple comparisons test. D) Quantification of the colocalized GFAP+ astrocytes with mCherry-labelled signal in the hippocampus using ImageJ shown as percentage of the total GFAP+ astrocytes. 8–10 male mice sampled. E) Representative images of MFG-E8 (white) immunoreactivity in the 6-mo WT and NL-F KI SR hippocampus post control or test CRISPR-saCas9 injection. Scale bar = 20 μm. F) Quantification of MFG-E8 immunoreactivity using ImageJ. Data shown as normalized to contra control CRISPR injected hemisphere. Transparent points = individual ROIs (3 ROIs per condition; 24 ROIs sampled in total per condition), full points = mouse average of ROIs (n=8 male mice per condition). Two-way ANOVA (Interaction: F (1, 28) = 218.6, p<0.0001) followed by Bonferroni’s multiple comparisons post-hoc test on Y=log(Y) transformed mouse average. G) Representative 3D rendered images of excitatory post-synaptic Homer1 (white), CD68 lysosomes (red) and P2Y12 (green) in the 6-mo WT and NL-F KI CA1 SR hippocampus post control or test CRISPR-saCas9 injection. Scale bar = 10 μm. Inset shows representative zoom of Homer1 inside CD68+ microglial lysosomes. H) Quantification of microglial Homer1 engulfment using Imaris 3D surface rendering shown as: Homer1 volume in CD68+ lysosomes in P2Y12+ microglial surface/P2Y12 volume x100. Transparent points = individual microglia (5–6 microglia per mouse; 24 WT control, 24 NL-F KI control, 24 WT test and 34 NL-F KI test injected microglia were sampled in total), full points = mouse average of ROIs (n=4–6 male mice per condition). Two-way ANOVA (Interaction: F (1, 14) = 4.929, p<0.05) followed by Bonferroni’s multiple comparisons post-hoc test on Y=log(Y) transformed mouse average. I) Representative images of excitatory post-synaptic Homer1 (green) and pre-synaptic Bassoon (magenta) immunostaining in the 6-mo WT and NL-F KI CA1 SR hippocampus post control or test CRISPR-saCas9 injection using super-resolution Airyscan confocal microscopy. Scale bar = 1 μm. Insets show regions of colocalization. J) Quantification of the number of colocalized Homer1 and Bassoon spots shown as density per μm3 using Imaris. Transparent points = individual ROIs (3 ROIs per mouse; 12 WT control, 12 NL-F KI control, 12 WT test and 15 NL-F KI test injected ROIs were sampled in total), full points = mouse average of ROIs (n=4–5 male mice per condition). Two-way ANOVA (Interaction: F (1, 13) = 11.02, p<0.01) followed by Bonferroni’s multiple comparisons post-hoc test on Y=log(Y) transformed mouse average. All data shown as mean ± SEM. p-values shown ns P>0.05; *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001.

References

    1. van Dyck C. H. et al. Synaptic density is associated with cognitive performance in Alzheimer’s disease: A PET imaging study with [11C]UCB J. Alzheimer’s & Dementia 17, (2021). - PMC - PubMed
    1. Mecca A. P. et al. In vivo measurement of widespread synaptic loss in Alzheimer’s disease with SV2A PET. Alzheimer’s and Dementia 16, 974–982 (2020). - PMC - PubMed
    1. DeKosky S. T. & Scheff S. W. Synapse loss in frontal cortex biopsies in Alzheimer’s disease: Correlation with cognitive severity. Ann Neurol 27, 457–464 (1990). - PubMed
    1. Scheff S. W., Price D. A., Schmitt F. A., Scheff M. A. & Mufson E. J. Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer’s disease. Journal of Alzheimer’s Disease 24, 547–557 (2011). - PMC - PubMed
    1. Scheff S. W., Price D. A., Schmitt F. A. & Mufson E. J. Hippocampal synaptic loss in early Alzheimer’s disease and mild cognitive impairment. Neurobiol Aging 27, 1372–1384 (2006). - PubMed

Publication types

LinkOut - more resources